Efficacy of Prostat in the treatment of NIH category IIIA prostatitis / 中华男科学杂志
National Journal of Andrology
; (12): 930-931, 2004.
Article
in Zh
| WPRIM
| ID: wpr-267776
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the efficacy of Prostat in the treatment of NIH category IIIA prostatitis.</p><p><b>METHODS</b>An open clinical trial was conducted among 106 NIH category IIIA prostatitis patients. For each patient 1 tablet of Prostat (70 mg P5 + 4 mg EA10) was orally administered twice a day.</p><p><b>RESULTS</b>Subjective symptoms of the patients were significantly improved, particularly those of frequent micturition, urgent urination and peripheral region pains. Objective parameters also showed significant improvement. No adverse reaction associated with the medication was observed.</p><p><b>CONCLUSION</b>Prostat was shown to be an appropriate medicine in the treatment of NIH category IIIA prostatitis, with good curative effect and high safety.</p>
Full text:
1
Index:
WPRIM
Main subject:
Pollen
/
Prostatitis
/
Treatment Outcome
/
Drug Therapy
/
Phytotherapy
Limits:
Adult
/
Humans
/
Male
Language:
Zh
Journal:
National Journal of Andrology
Year:
2004
Type:
Article